Feline immunodeficiency virus

Feline immunodeficiency virus
Name	Feline immunodeficiency virus
Virus group	Retroviridae, Lentivirus
Hosts	Felidae
Transmission	Horizontal contact, bites

Feline immunodeficiency virus is a lentivirus of the family Retroviridae that causes an acquired immunodeficiency syndrome in domestic cats and some wild felids. First described in the 1980s, the virus has been studied by virologists at institutions such as Centers for Disease Control and Prevention, National Institutes of Health, University of California, Davis, and researchers associated with World Health Organization training programs. Research on the virus intersects with work at Smithsonian Institution collections, field studies in regions like South Africa, Australia, and Thailand, and comparative investigations alongside pathogens studied at Johns Hopkins Hospital and Massachusetts General Hospital.

Virology and Classification

Feline immunodeficiency virus is classified within the family Retroviridae and the genus Lentivirus, a grouping that also includes agents investigated at Institute Pasteur, Cold Spring Harbor Laboratory, and National Institute of Allergy and Infectious Diseases. Molecular taxonomy relies on sequence comparisons with isolates characterized by laboratories at Harvard University, Stanford University, and University of Edinburgh. Genome organization—gag, pol, env, and accessory genes—has been mapped using techniques developed at Max Planck Society centers and sequencing platforms used by consortia including Wellcome Trust and European Molecular Biology Laboratory. Phylogeographic studies link clades to fieldwork by teams from University of Cape Town, Monash University, and Chulalongkorn University.

Transmission and Epidemiology

Transmission is primarily via biting and saliva during aggressive encounters, a pattern documented in urban studies coordinated with municipal agencies like New York City Department of Health and Mental Hygiene and wildlife surveys involving National Park Service staff. Epidemiological surveys have been conducted in regions monitored by Australian Department of Agriculture, South African National Biodiversity Institute, and veterinary networks connected to Royal Veterinary College and Cornell University. Prevalence varies by population density, social behavior, and control measures studied by public health teams from University of Sydney, University of São Paulo, and Kyoto University. Wild felid reservoirs and spillover events have been investigated by researchers affiliated with World Wildlife Fund, International Union for Conservation of Nature, and museum programs at American Museum of Natural History.

Clinical Signs and Pathogenesis

Clinical progression mirrors lentiviral immunosuppression described in comparative studies at Mayo Clinic, Cleveland Clinic, and Veterinary Hospital of the University of Pennsylvania. Acute infection can present with fever, lymphadenopathy, and lethargy noted in case series reported by veterinary clinics linked to Banfield Pet Hospital, VCA Animal Hospitals, and academic hospitals like Tufts Veterinary School. Chronic phases include opportunistic infections and neoplasia paralleling findings in human immunodeficiency research from University College London and Imperial College London. Pathogenesis involves CD4+ T-cell depletion and immune dysregulation studied in basic science labs at Salk Institute, Riken Institute, and Karolinska Institutet.

Diagnosis

Diagnosis relies on serological assays and molecular tests developed through collaborations with diagnostic manufacturers and research centers such as Abbott Laboratories, Roche Diagnostics, and university laboratories at Michigan State University and Iowa State University. Enzyme-linked immunosorbent assay and Western blot methods, refined in laboratories like Pasteur Institute, are supplemented by polymerase chain reaction protocols standardized by groups at Centers for Disease Control and Prevention and quality-assured through programs with World Organisation for Animal Health. Clinical diagnostic pathways are informed by guidelines from professional bodies including American Veterinary Medical Association and British Veterinary Association.

Treatment and Management

There is no definitive cure; management strategies include supportive care, antimicrobial stewardship, and symptomatic treatment protocols derived from comparative medicine research at Ohio State University, University of Wisconsin–Madison, and North Carolina State University. Antiretroviral drugs used experimentally or off-label have been evaluated in trials modeled after work at UCSF Medical Center, Mayo Clinic, and translational programs at Fred Hutchinson Cancer Research Center. Management emphasizes nutrition and parasite control protocols echoed in guidelines from Association of American Veterinary Medical Colleges and shelter medicine practices at organizations like Humane Society of the United States and Best Friends Animal Society.

Prevention and Control

Control measures focus on testing, behavioral modification, and population management strategies promoted by municipal shelters in cities such as Los Angeles, Chicago, and London, and global initiatives by World Animal Protection and International Fund for Animal Welfare. Vaccination efforts have been reported from research groups at University of Florida, University of Glasgow, and biotech firms supported by grants from National Science Foundation and philanthropic funding like Gates Foundation–style programs for animal health. Public education campaigns coordinated with local veterinary boards and animal welfare NGOs such as Royal Society for the Prevention of Cruelty to Animals aim to reduce transmission through neutering, indoor housing, and management protocols used in trap–neuter–release programs pioneered in cities like New York City and promoted by networks including Alley Cat Allies.

Category:Viral diseases of cats